Clinical Trial Update: Thermal Ablation Followed by Immunotherapy for HCC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update exploring thermal ablation followed by immunotherapy for non-resectable hepatocellular carcinoma in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 1, Phase 2 | Status: UNKNOWN